China Healthwise Holdings Limited provided unaudited consolidated group earnings guidance for the half year of 2022. For the period, the group expects to record a loss attributable to owners of the Company within a range of approximately HKD 15 million to approximately HKD 23 million, as compared to a profit attributable to owners of the Company of HKD 37 million for the half year of 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.063 HKD | +5.00% | +21.15% | +53.66% |
Mar. 26 | China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 21 | China Healthwise to Widen Losses in 2023 | MT |
1st Jan change | Capi. | |
---|---|---|
+53.66% | 6.2M | |
+17.35% | 71.39B | |
+2.39% | 25.1B | |
+5.38% | 8.59B | |
+6.69% | 8.19B | |
-20.96% | 7.91B | |
+0.49% | 4.54B | |
+17.12% | 4.31B | |
-2.61% | 3.86B | |
+22.08% | 3.64B |
- Stock Market
- Equities
- 348 Stock
- News China Healthwise Holdings Limited
- China Healthwise Holdings Limited Provides Unaudited Consolidated Group Earnings Guidance for the Half Year of 2022